glp-1 news november 6 2025 Ozempic Statistics: Weight Loss Medication Data GLP-1 drugs can be ‘too

Standard GLP-1 receptor agonists such as semaglutide work by enhancing insulin secretion, suppressing appetite, and slowing gastric emptying

Patients with favorable GLP1R and GIPR variants often show stronger response to semaglutide monotherapy, while those with certain FTO or MC4R patterns may benefit from dual-compound protocols like GLP-Squared

Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial

Castaeda, T

GLP-1 receptors have been identified in bone mesenchymal stem cells, indicating a broader physiological role for these incretin hormones

Maintenance dose: Around $349/month self-pay